Alzheimer’s disease

Gemvax & Kael Co. Ltd. focuses its clinical research on Alzheimer’s disease, with an emphasis on mild to moderate cognitive impairment and cognition in affected participants.

• Neurodegenerative disease research
• Cognitive function assessment
• Safety evaluation in Alzheimer’s disease

The sponsor’s active trial portfolio includes work across multiple collaborating sites in Asia and other participating countries, reflecting a clinical interest centered on treatment options for Alzheimer’s disease.